Antibiotics and Uterine Flushing versus Antibiotics Alone for Chronic Endometritis with Thin Endometrium in Assisted Reproductive Technology: A Single-Center Retrospective Cohort Study

辅助生殖技术中,慢性子宫内膜炎伴子宫内膜薄患者接受抗生素联合子宫冲洗与单独使用抗生素治疗的疗效比较:一项单中心回顾性队列研究

阅读:1

Abstract

BACKGROUND: This study aimed to investigate whether uterine cavity flushing combined with antibiotic administration, improves the outcomes of assisted reproductive technology for patients with thin endometrium (<7 mm) associated with chronic endometritis. MATERIALS AND METHODS: A retrospective cohort study was conducted, including 202 patients. Subsequently, a single frozen-thawed embryo of high morphological quality (≥4AB) was transferred either in an artificial cycle or on day 7 after the luteinizing hormone (LH) peak in the natural cycle. The parameters measured included the number of CD138-positive plasma cells in the endometrial stroma, endometrial thickness on the day of embryo transfer, clinical pregnancy rate (CPR), and live birth rate (LBR). RESULTS: Following treatment with endometrial flushing and antibiotics (group 1), there was a significant increase in endometrial thickness compared to antibiotics alone (group 2): 9.93 ± 1.37 mm vs. 8.2 ± 0.4 mm (P<0.001). Additionally, there was a significant reduction in the number of CD138-positive plasma cells in the endometrial stroma: 0.4 ± 0.8 vs. 4.1 ± 5.2 (P<0.001). The CPR with high-quality ET was 68.6 vs. 48%, respectively (P=0.016). The take-home baby rate was 60.8 vs. 39%, respectively (P=0.002). CONCLUSION: Therapy for chronic endometritis, which includes uterine flushing along with antibacterial treatment, when compared with the standard treatment method, resulted in a significant reduction in the clinical symptoms of chronic endometritis (CE) and can enhance the effectiveness of assisted reproductive technology treatments.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。